Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


APPLICATION SITE INFLAMMATION side effect

What is APPLICATION SITE INFLAMMATION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   APPLICATION SITE INFLAMMATION and Recently Reported Side Effects   APPLICATION SITE INFLAMMATION and 15 most Active Side Effect polls   APPLICATION SITE INFLAMMATION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with APPLICATION SITE INFLAMMATION

ALTABAX  CATAPRES  EPIPEN  EPIRUBICIN  FENTANYL  FINACEA  FOCALIN  GLIADEL  MINOXIDIL  ROGAINE  SANTYL  


Rogaine Side Effects Report #5556258-9
Pharmacist from GERMANY reported ROGAINE problem on Nov 23, 2007. Female patient, 57 years of age, weighting 242.5 lb, was diagnosed with alopecia effluvium and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: application site inflammation, blood pressure fluctuation, burning sensation, eczema, hypertensive crisis, . ROGAINE dosage: 1 ML TWICE DAILY (1 ML, 2 IN 1 D), TOPICAL. During the same period patient was treated with RAMIPRIL, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Altabax Side Effects Report #5511336-5
ALTABAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, 45 years of age, was diagnosed with staphylococcal infection and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site inflammation, application site swelling, . ALTABAX dosage: unknown. During the same period patient was treated with BACTRIM DS. Patient recovered.

Epirubicin Side Effects Report #5310800-1
Physician from BELGIUM reported EPIRUBICIN HYDROCHLORIDE problem on Apr 17, 2007. Female patient, weighting 149.9 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: application site inflammation, extravasation, lymphoedema, skin necrosis, . EPIRUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Gliadel Side Effects Report #5619126-X
GLIADEL problem was reported by a Physician from UNITED STATES on Jan 22, 2008. Male patient, 39 years of age, was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: application site discharge, application site inflammation, brain mass, intracranial hypotension, leukocytosis, post procedural complication, purulence, pyrexia, surgical procedure repeated, . GLIADEL dosage: unknown. During the same period patient was treated with DILANTIN, KEPPRA. Patient was hospitalized. Patient recovered.


Epipen Side Effects Report #5623089-0
Pharmacist from UNITED KINGDOM reported EPIPEN problem on Feb 04, 2008. Female patient was diagnosed with anaphylaxis prophylaxis, hypersensitivity and was treated with EPIPEN. After drug was administered, patient experienced the following problems/side effects: allergy to chemicals, application site inflammation, . EPIPEN dosage: .3 MG, SINGLE. During the same period patient was treated with CORTICOSTEROIDS, ANTIHISTAMINES. Patient was hospitalized. Patient recovered.

Finacea Side Effects Report #5629229-1
FINACEA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2007. Female patient, 38 years of age, weighting 108.0 lb, was diagnosed with acne and was treated with FINACEA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site pruritus, cyst, scar, . FINACEA dosage: unknown. Patient recovered.

Santyl Side Effects Report #5630327-7
Physician from UNITED STATES reported SANTYL problem on Jan 29, 2008. Female patient, 71 years of age, was diagnosed with complex regional pain syndrome, ulcer and was treated with SANTYL. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site pain, pseudomonas infection, wound infection staphylococcal, . SANTYL dosage: unknown. During the same period patient was treated with PREDNISONE, OMEPRAZOLE, PERCOCET, TRAZODONE, NOVOLOG, HYDROMORPHONE. Patient recovered.

Catapres Side Effects Report #5555870-0
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Male patient, 17 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site pruritus, . CATAPRES dosage: unknown. Patient recovered.

Altabax Side Effects Report #5511304-3
Consumer or non-health professional from UNITED STATES reported ALTABAX problem on Sept 04, 2007. Male patient, 50 years of age, was diagnosed with wound and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site irritation, application site pain, cold sweat, feeling cold, hypersensitivity, swollen tongue, . ALTABAX dosage: unknown. During the same period patient was treated with DOXYCYCLINE. Patient recovered.


Fentanyl Side Effects Report #5503744-3
FENTANYL PATCHES problem was reported by a Health Professional from UNITED STATES on Oct 30, 2007. Female patient, weighting 165.0 lb, was diagnosed with lumbar radiculopathy, pain and was treated with FENTANYL PATCHES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site inflammation, application site rash, application site reaction, application site warmth, hyperaesthesia, . FENTANYL PATCHES dosage: unknown. During the same period patient was treated with FENTANYL PATCHES. Patient recovered.

Focalin Side Effects Report #5787060-0
Consumer or non-health professional from UNITED STATES reported FOCALIN problem on June 23, 2008. Female patient, weighting 130.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with FOCALIN. After drug was administered, patient experienced the following problems/side effects: application site discomfort, application site inflammation, application site irritation, depressed mood, depression, disturbance in social behaviour, fatigue, heart rate increased, impulsive behaviour, . FOCALIN dosage: unknown. During the same period patient was treated with DAYTRANA. Patient recovered.

Minoxidil Side Effects Report #5757637-7
MINOXIDIL problem was reported by a Pharmacist from AUSTRALIA on May 16, 2008. Male patient, 57 years of age, was diagnosed with alopecia and was treated with MINOXIDIL. After drug was administered, patient experienced the following problems/side effects: application site burn, application site inflammation, burning sensation, feeling abnormal, . MINOXIDIL dosage: 1 ML ONCE DAILY (1 ML, 1 IN 1 D), TOPICAL. Patient recovered.

Fentanyl Side Effects Report #5694294-2
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Mar 24, 2008. Female patient, weighting 180.0 lb, was diagnosed with back pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site discharge, application site inflammation, arthritis, back pain, fall, gait disturbance, memory impairment, weight increased, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, VICODIN. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about APPLICATION SITE INFLAMMATION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about APPLICATION SITE INFLAMMATION